Stock IMMU MENDUS AB
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Mendus AB

Equities

IMMU

SE0022239950

Delayed Nasdaq Stockholm
Other stock markets
 13:30:51 24/06/2024 BST 		5-day change 1st Jan Change
8.89 SEK -2.74% Intraday chart for Mendus AB -2.52% -15.01%
05-17 Transcript : Mendus AB, Q1 2024 Earnings Call, May 17, 2024
05-17 Mendus AB Announces Board Changes CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Immunicum Announces Phase I/II Data Showing Tumor Specific Immune Responses That Directly Correlate with Prolonged Survival Rates for the Majority of Liver Cancer Patients Treated with INTUVAX
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMMU Stock
  4. News Mendus AB
  5. Analyst Reco.